Camber Spine Technologies SPIRA - V™ Open Matrix Corpectomy Cage

K173800 · Camber Spine Technologies · MQP · Feb 2, 2018 · Orthopedic

Device Facts

• Record ID: K173800
• Device Name: Camber Spine Technologies SPIRA - V™ Open Matrix Corpectomy Cage
• Applicant: Camber Spine Technologies
• Product Code: MQP · Orthopedic
• Decision Date: Feb 2, 2018
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3060
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy Cage is indicated for use in the Thoracolumbar Spine (T1-L5) to replace collapsed, or an unstable vertebral body due to tumor or trauma (i.e., fracture). The Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy is intended to be used with additional FDA-cleared supplementary fixation systems. The Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy Cage system must be used with autogenous graft material.

Device Story

Spinal implant; corpectomy cage; replaces collapsed/unstable vertebral bodies in thoracolumbar spine (T1-L5). Features spiral supports creating hollow chamber for autogenous bone graft packing to facilitate fusion; rough superior/inferior surfaces prevent migration. Implanted by surgeons during spinal surgery; requires concurrent use of FDA-cleared supplementary fixation systems. Provides structural support to vertebral column; promotes bone fusion; restores spinal stability.

Clinical Evidence

Bench testing only. Performed static compression, static torsion, dynamic compression, dynamic torsion, subsidence, and expulsion testing per ASTM F2077-14 and F2267-04. Particulate analysis performed per ASTM F1877-16. Results met acceptance criteria defined by predicate device performance.

Technological Characteristics

Spinal intervertebral body fixation orthosis; spiral support design; hollow chamber for bone graft. Mechanical testing per ASTM F2077-14, F2267-04; particulate analysis per ASTM F1877-16.

Indications for Use

Indicated for patients with collapsed, damaged, or unstable vertebral bodies in the thoracolumbar spine (T1-L5) resulting from tumor or trauma (fracture). Must be used with autogenous bone graft and supplementary fixation.

Regulatory Classification

Identification

A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.

Predicate Devices

• Camber Spine VERTA (K143490)
• Osteotech VBR (K012254)
• Interpore Geo Structure (K010530)

Reference Devices

• Camber Spine SPIRA-C Open Matrix Cervical Interbody (K172446)
• Rezaian Fixator (K841189)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. Food & Drug Administration" in blue.

February 2, 2018

Camber Spine Technologies % Mr. Justin Eggleton Senior Director, Spine Regulatory Affairs Musculoskeletal Clinical Regulatory Advisers, LLC 1050 K Street NW, Suite 1000 Washington, District of Columbia 20001

Re: K173800

Trade/Device Name: Camber Spine Technologies SPIRA - V™ Open Matrix Corpectomy Cage Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal Intervertebral Body Fixation Orthosis Regulatory Class: Class II Product Code: MOP Dated: December 13, 2017 Received: December 14, 2017

Dear Mr. Eggleton:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);

{1}------------------------------------------------

## Page 2 - Mr. Justin Eggleton

and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

# Katherine D. Kavlock -S

for Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K173800

Device Name

Camber Spine Technologies SPIRA-VTM Open Matrix Corpectomy Cage

### Indications for Use (Describe)

The Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy Cage is indicated for use in the Thoracolumbar Spine (T1-L5) to replace collapsed, or an unstable vertebral body due to tumor or trauma (i.e., fracture). The Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy is intended to be used with additional FDA-cleared supplementary fixation systems.

The Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy Cage system must be used with autogenous graft material.

### Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

### PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

### FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## 510(k) Summary

| Device Trade Name: | Camber Spine Technologies SPIRA-VTM Open Matrix<br>Corpectomy Cage |
|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer: | Camber Spine Technologies<br>418 E. Lancaster Ave.<br>Wayne, PA 19087 |
| Contact: | Mr. Daniel Pontecorvo<br>CEO<br>Phone: [phone] |
| Prepared by: | Justin Eggleton<br>Musculoskeletal Clinical Regulatory Advisers, LLC<br>1050 K Street NW, Suite 1000<br>Washington, DC 20001<br>Phone: [phone]<br>[e-mail] |
| Date Prepared: | January 23, 2018 |
| Classifications: | 21 CFR §888.3060, Spinal intervertebral body fixation orthosis |
| Class: | II |
| Product Codes: | MQP |
| Primary Predicate: | Camber Spine VERTA (K143490) |
| Additional Predicates: | Osteotech VBR (K012254), Interpore Geo Structure (K010530) |
| Reference Devices: | Camber Spine SPIRA-C Open Matrix Cervical Interbody<br>(K172446), Rezaian Fixator (K841189) |

## Indications for Use:

The Camber Spine Technologies SPIRA-VI™ Open Matrix Corpectomy Cage is indicated for use in the Thoracolumbar Spine (T1-L5) to replace collapsed, damaged, or an unstable vertebral body due to tumor or trauma (i.e., fracture). The Camber Spine Technologies SPIRA-VIM Open Matrix Corpectomy is intended to be used with additional FDA-cleared supplementary fixation systems.

The Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy Cage system must be used with autogenous graft material.

{4}------------------------------------------------

### Device Description:

The Camber Spine Technologies SPIRA-VIM Open Matrix Corpectomy Cage is a device that has spiral supports to allow for a hollow chamber to permit packing with autogenous bone to facilitate fusion. The superior and inferior surfaces of the device have a rough surface to help prevent movement of the device while fusion takes place.

### Predicate Device:

The subject Camber Spine Technologies SPIRA-V™ Open Matrix Corpectomy Cage is equivalent to the primary predicate device, Camber Spine VERTA (K143490). Additional predicates were presented, including the Osteotech VBR (K012254) and Interpore Geo Structure (K010530). Comparisons were made to reference devices. including the Camber Spine SPIRA-C Open Matrix Cervical Interbody (K172446) and Rezaian Fixator (K841189).

### Performance Testing Summary:

Testing performed indicate that the Camber Spine Technologies SPIRA-V Open Matrix Corpectomy Cage is as mechanically sound as predicate devices. Testing included static compression, static torsion, dynamic compression, dynamic torsion, subsidence, and expulsion per ASTM F2077-14 and F2267-04. A particulate analysis was performed in accordance with ASTM F1877-16. The results demonstrate that the acceptance criteria defined by predicate device performance were met.

### Substantial Equivalence:

The subject Camber Spine Technologies SPIRA-VI™ Open Matrix Corpectomy Cage is equivalent to the primary predicate device, Camber Spine VERTA (K143490) with respect to indications, design, materials, function, manufacturing, and/or performance. Additional predicates were presented, including the Osteotech VBR (K012254) and Interpore Geo Structure (K010530). Comparisons were made to reference devices, including the Camber Spine SPIRA-C Open Matrix Cervical Interbody (K172446) and Rezaian Fixator (K841189).

### Conclusion:

Camber Spine Technologies provided sufficient information to demonstrate the Camber Spine Technologies SPIRA-V Open Matrix Corpectomy Cage is equivalent to primary predicate, Camber Spine VERTA (K143490) with respect to indications, design, materials, function, manufacturing, and/or performance. Additional predicates, Osteotech VBR (K012254) and Interpore Geo Structure (K010530), were presented for additional comparisons. Additional comparisons were made to other reference devices, including the Camber Spine SPIRA-C Open Matrix Cervical Interbody (K172446), Rezaian Fixator (K841189).